Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Egan

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Journal of the Neurological Sciences|August 28, 2022
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic strokeS T Lim, S J X Murphy, S M Murphy, et al.
Journal of Neurology|May 1, 2014
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic strokeW O Tobin, J A Kinsella, G F Kavanagh, et al.
Scientific Reports|March 7, 2019
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencingAlan H Bryce, Jan B Egan, James B Smadbeck, et al.
Journal of the Neurological Sciences|July 18, 2024
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapyD R Smith, S T Lim, S J X Murphy, et al.
Prostate Cancer and Prostatic Diseases|July 23, 2021
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancerMiguel Gonzalez Velez, Heidi E Kosiorek, Jan B Egan, et al.
Leukemia|June 12, 2013
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276J Schmidt, E Braggio, K M Kortuem, et al.
Blood|April 25, 2012
Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tidesJan B Egan, Chang-Xin Shi, Waibhav Tembe, et al.
Journal of the Neurological Sciences|March 22, 2017
Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypesW O Tobin, J A Kinsella, G F Kavanagh, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 16, 2010
The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful agingMark R Haussler, Carol A Haussler, G Kerr Whitfield, et al.
BMC Medical Informatics and Decision Making|February 21, 2020
Designing a mHealth clinical decision support system for Parkinson's disease: a theoretically grounded user needs approachL Timotijevic, C E Hodgkins, A Banks, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Journal of the Neurological Sciences|August 28, 2022
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic strokeS T Lim, S J X Murphy, S M Murphy, et al.
Journal of Neurology|May 1, 2014
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic strokeW O Tobin, J A Kinsella, G F Kavanagh, et al.
Scientific Reports|March 7, 2019
Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencingAlan H Bryce, Jan B Egan, James B Smadbeck, et al.
Journal of the Neurological Sciences|July 18, 2024
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapyD R Smith, S T Lim, S J X Murphy, et al.
Prostate Cancer and Prostatic Diseases|July 23, 2021
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancerMiguel Gonzalez Velez, Heidi E Kosiorek, Jan B Egan, et al.
Leukemia|June 12, 2013
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276J Schmidt, E Braggio, K M Kortuem, et al.
Blood|April 25, 2012
Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tidesJan B Egan, Chang-Xin Shi, Waibhav Tembe, et al.
Journal of the Neurological Sciences|March 22, 2017
Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypesW O Tobin, J A Kinsella, G F Kavanagh, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 16, 2010
The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful agingMark R Haussler, Carol A Haussler, G Kerr Whitfield, et al.
BMC Medical Informatics and Decision Making|February 21, 2020
Designing a mHealth clinical decision support system for Parkinson's disease: a theoretically grounded user needs approachL Timotijevic, C E Hodgkins, A Banks, et al.
Pageof 22